A challenging case of drug-related acute fibrinous and organizing pneumonia: A rare case report

RESPIROLOGY CASE REPORTS(2024)

引用 0|浏览2
暂无评分
摘要
A 65-year-old man presented with intermittent fever and progressive shortness of breath. He responded poorly to antibiotics and corticosteroids (methylprednisolone 40 mg/d). Chest computed tomography scans showed diffuse consolidations and ground glass density patchy opacities in both lungs and these lesions progressed rapidly. The diagnosis of acute fibrinous and organizing pneumonia (AFOP) was confirmed through transbronchial cryobiopsy. This patient had prostate cancer with bone metastasis for 4 months and took the anti-prostate cancer medications including apalutamide and leuprorelin acetate. Considering his medication history, the patient was diagnosed with AFOP induced by anti-prostate cancer medications through panel discussion of multidisciplinary teams. Intravenous methylprednisolone of 500 mg/day was administered for 3 days and then slowly tapered. The patient's shortness of breath gradually subsided. In addition, the lesions in the lungs improved significantly on follow up imaging. AFOP induced by anti-prostate cancer medications is rare. To our knowledge, this is the first reported case and high-dose glucocorticoid treatment may be required in some of these cases. Acute fibrinous and organizing pneumonia (AFOP) is a rare type of interstitial pneumonia. We present a case of AFOP probably induced by anti-prostate cancer medications. image
更多
查看译文
关键词
acute fibrinous and organizing pneumonia (AFOP),apalutamide,interstitial lung disease,leuprorelin acetate,prostate cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要